宏潤建設(002062.SZ):擬約12億元投資集中式光伏電站項目 規模不少於300MW
格隆匯3月7日丨宏潤建設(002062.SZ)公佈,公司(“乙方”)與宣城市宣州區人民政府於2023年3月7日簽署了《戰略合作框架協議》,為推進項目實施,同日,公司與宣城市宣州區人民政府(簡稱“甲方”)簽署了《300MW集中式光伏電站項目投資開發協議》,該項目總投資約為12億元,投資方式包括但不限於公司獨資或者與央企、國企等戰略合作方合資等形式。
該項目擬在安徽宣城高新技術產業開發區內設立項目公司開展投資運營。擬投資集中式光伏電站項目規模不少於300MW,其中計劃在宣城市宣州區狸橋鎮實施150MW漁光互補項目,在宣城市宣州區楊柳鎮實施150MW茶光互補項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.